NCT00663442View on ClinicalTrials.gov

Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
ADHD
Interventions
DRUG

OROS methylphenidate

18, 36, 54 mg

Trial Locations (1)

60608

HALP Clinic, University of Illinois at CHicago, Chicago

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Illinois at Chicago

OTHER

NCT00663442 - Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter